We hope those that joined this session gained valuable insights into the world of Humira, its clinical significance and its financial implications. During the webinar, the speakers discussed:
- The financial burden of Humira on health plans
- The rise of biosimilars
- Effective strategies for cost reduction
- Actionable next steps for immediate impact in managing healthcare budgets